Aprendendo sobre o câncer de mama
Stage 4 survival depends on biology of tumor... I know for stage 4 her2 plus that has not responded to Herceptin ... 25 percent die within 3 years, 50 percent at 3 years and 25 percent live on.. This was told to me last Spring... With perjeta newly approved and being used I don't know how it has changed these statistics... Science will continually be improving these numbers and we never know who the 25 percent are that just keep living... So best bet is live your good life!